Optimized Prime Editing of Human Induced Pluripotent Stem Cells to Efficiently Generate Isogenic Models of Mendelian Diseases
Authors:
- Rodrigo Cerna-ChavezRCRodrigo Cerna-Chavez
- Alba Ortega-GascoAOAlba Ortega-Gasco
- Hafiz Muhammad Azhar BaigHBHafiz Muhammad Azhar Baig
- Nathan EhrenreichNENathan Ehrenreich
- Thibaud MetaisTMThibaud Metais
- Michael J. ScanduraMSMichael J. Scandura
- Kinga BujakowskaKBKinga Bujakowska
- Eric A. PierceEPEric A. Pierce
- Marcela Garita-HernandezMarcela Garita-Hernandez
Open Access
- 26 December 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (1) , 114
Abstract
Prime editing (PE) is a CRISPR-based tool for genome engineering that can be applied to generate human induced pluripotent stem cell (hiPSC)-based disease models. PE technology safely introduces point mutations, small insertions, and deletions (indels) into the genome. It uses a Cas9-nickase (nCas9) fused to a reverse transcriptase (RT) as an editor and a PE guide RNA (pegRNA), which introduces the desired edit with great precision without creating double-strand breaks (DSBs). PE leads to minimal off-targets or indels when introducing single-strand breaks (SSB) in the DNA. Low efficiency can be an obstacle to its use in hiPSCs, especially when the genetic context precludes the screening of multiple pegRNAs, and other strategies must be employed to achieve the desired edit. We developed a PE platform to efficiently generate isogenic models of Mendelian disorders. We introduced the c.25G>A (p.V9M) mutation in the NMNAT1 gene with over 25% efficiency by optimizing the PE workflow. Using our optimized system, we generated other isogenic models of inherited retinal diseases (IRDs), including the c.1481C>T (p.T494M) mutation in PRPF3 and the c.6926A>C (p.H2309P) mutation in PRPF8. We modified several determinants of the hiPSC PE procedure, such as plasmid concentrations, PE component ratios, and delivery method settings, showing that our improved workflow increased the hiPSC editing efficiency.Keywords
Funding Information
- National Eye Institute (EY012910, EY020902, EY014104)
- National Institutes of Health (EY012910, EY020902, EY014104)
- Knights Templar Eye Foundation Career starter research grant (EY012910, EY020902, EY014104)
- competitive renewal grants (MG-H) (EY012910, EY020902, EY014104)
This publication has 102 references indexed in Scilit:
- Enhanced prime editing systems by manipulating cellular determinants of editing outcomesCell, 2021
- Inborn errors of metabolism: Lessons from iPSC modelsReviews in Endocrine and Metabolic Disorders, 2021
- Pluripotent stem cell-derived retinal organoids for disease modeling and development of therapiesStem Cells, 2020
- Stem Cells, Genome Editing, and the Path to Translational MedicineCell, 2018
- IGF-1 Signaling Plays an Important Role in the Formation of Three-Dimensional Laminated Neural Retina and Other Ocular Structures From Human Embryonic Stem CellsStem Cells, 2015
- Mutations in Pre-mRNA Processing Factors 3, 8, and 31 Cause Dysfunction of the Retinal Pigment EpitheliumThe American Journal of Pathology, 2014
- Modeling Human Retinal Development with Patient-Specific Induced Pluripotent Stem Cells Reveals Multiple Roles for Visual System Homeobox 2Stem Cells, 2014
- LOVD v.2.0: the next generation in gene variant databasesHuman Mutation, 2011
- Prognosis for splicing factor PRPF8 retinitis pigmentosa, novel mutations and correlation between human and yeast phenotypesHuman Mutation, 2010
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006